Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Spectral Medical Inc. (OTC: EDTXF).

Full DD Report for EDTXF

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-110.190.18890.190.188912,004
2018-12-100.1760.190.190.17613,028
2018-12-070.18220.18310.18310.182226,200
2018-12-060.178890.184940.184940.177315,200
2018-12-050.18430.18430.18430.184313,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1111,50412,00495.8347Short
2018-10-1667,50078,14986.3735Short
2018-10-03400400100.0000Short
2018-09-279,50040,66623.3610Cover
2018-09-2518,12523,00078.8043Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EDTXF.


About Spectral Medical Inc. (OTC: EDTXF)

Logo for Spectral Medical Inc. (OTC: EDTXF)

Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company s Endotoxin Activity Assay EAA , the only FDA cleared diagnostic for the risk of developing sepsis, Spectral s EUPHRATES trial is the world s first theranostics trial in the area of sepsis.

 

Contact Information

 

 

Current Management

  • Paul M. Walker / President, CEO
  • Anthony Businskas / EVP, CFO, IR
  • Debra M. Foster / VP, Clinical Development
  • Anthony Bihl III / Chairman
  • Anthony Businskas /
  • Kevin Giese /
  • Guillermo Herrera /
  • William Stevens /
  • Koichiro Takeshita /
  • Paul M. Walker /

Current Share Structure

  • Market Cap: $65,990,085 - 03/09/2018
  • Authorized: 212,414,709 - 03/31/2016
  • Issue and Outstanding: 206,865,470 - 09/30/2016

 



Daily Technical Chart for (OTC: EDTXF)

Daily Technical Chart for (OTC: EDTXF)


Stay tuned for daily updates and more on (OTC: EDTXF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: EDTXF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EDTXF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EDTXF and does not buy, sell, or trade any shares of EDTXF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/